US Patent 10183024 Crystalline forms of ibrutinib
Patent 10183024 was granted and assigned to Apotex on January, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 30, 2017
Date of Patent
January 22, 2019
Patent Applicant
Patent Application Number
15827471
Patent Inventor Names
Fabio E. S. Souza
0
Annyt Bhattacharyya
0
Bahareh Khalili
0
Boris Gorin
0
Allan W. Rey
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10183024 Crystalline forms of ibrutinib
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.